Search

Sartorius Stedim Biotech.

Open

SectorFinance

167.9 -1.06

Overview

Share price change

24h

Current

Min

167.6

Max

172.9

Key metrics

By Trading Economics

Income

4.9M

93M

Sales

4.2M

766M

P/E

Sector Avg

54.053

18.576

EPS

1.29

Dividend yield

0.41

Profit margin

12.146

Employees

10,477

EBITDA

9.2M

240M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+35.21% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.41%

4.62%

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

-1.7B

16B

Previous open

168.96

Previous close

167.9

News Sentiment

By Acuity

13%

87%

14 / 438 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

30 Jul 2026, 23:56 UTC

News

Old Dominion Freight Line shares lower in after-market hours after UBS raised its price target to $228 while maintaining a Neutral rating.

30 Jul 2026, 23:56 UTC

News

DICK'S Sporting Goods Inc. sees gains in after-market trading, supported by solid fundamentals and recognition as a value stock despite mixed performance momentum.

30 Jul 2026, 23:56 UTC

News

Viking Therapeutics Inc. shows a modest gain in after-market hours amid a wave of biopharmaceutical mergers, including Vertex's $10 billion acquisition of Crinetics.

30 Jul 2026, 23:56 UTC

News

Check Point Software Technologies reported earnings of $2.55 per share, surpassing expectations of $2.45. Shares are little changed in after-market trading.

30 Jul 2026, 23:52 UTC

News
Social Media

Amazon.com Inc shares rose in after-hours trading following strong second-quarter results, with net sales of $200.6 billion surpassing analyst expectations.

30 Jul 2026, 23:51 UTC

News

Kimberly-Clark announced a $10 million commitment for recovery efforts in Wisconsin's Fox Valley, moving higher in after-market hours amid broader market gains.

30 Jul 2026, 23:51 UTC

News

Boston Scientific shares are higher in after-market trading following UBS's Buy rating and a price target adjustment to $67 amid Penumbra's results.

30 Jul 2026, 23:51 UTC

News

Castle Biosciences reported second-quarter revenues of $103.5 million, exceeding estimates. Shares are sharply higher in after-market trading following the earnings and guidance update.

30 Jul 2026, 23:51 UTC

News

Hercules Capital reported second-quarter earnings of $0.50 per share, exceeding estimates. Shares are higher in after-market trading following the strong results.

30 Jul 2026, 23:51 UTC

Correlated Moves
News

EMCOR Group Inc. reported record second-quarter results, with revenue of $5.15 billion and EPS of $9.06, raising full-year guidance. Shares are higher in after-market hours.

30 Jul 2026, 23:51 UTC

Social Media
Correlated Moves
News

Lam Research Corp shares rose in after-market hours following strong second-quarter results, with adjusted EPS of $1.82 and optimistic third-quarter revenue guidance of $8.1 billion.

30 Jul 2026, 23:51 UTC

News
Social Media

Dexcom reported second-quarter revenue of $1.308 billion and adjusted EPS of $0.70, raising its fiscal year 2026 revenue guidance, with shares trading higher in after-market hours.

30 Jul 2026, 23:51 UTC

News
Social Media

Roblox Corp shares fell in after-hours trading following a narrower net loss of $183 million but disappointing revenue and guidance for third-quarter bookings.

30 Jul 2026, 23:51 UTC

News
Social Media

Replimune Group shares are advancing in after-market trading following a favorable FDA advisory vote on its melanoma treatment RP1, despite earlier declines during the session.

30 Jul 2026, 23:51 UTC

News
Event
Social Media

Apple Inc reported fiscal Q3 revenue of $109.4 billion, but shares fell in after-hours trading due to weaker-than-expected guidance and missed services revenue.

30 Jul 2026, 23:46 UTC

News

TFS Financial Corp reported third-quarter EPS of $0.11, surpassing estimates. Shares are higher in after-market trading following strong earnings and revenue results.

30 Jul 2026, 23:46 UTC

News

Eastman Chemical Co reported second-quarter net earnings of $183 million, up from $140 million last year, with shares trading roughly flat in after-market hours.

30 Jul 2026, 23:46 UTC

Correlated Moves
News

UBS raised its price target on Xylem Inc. to $135, as shares traded higher in after-market hours following a dip earlier in the session.

30 Jul 2026, 23:46 UTC

Social Media
News

Yum Brands reported a cyclospora outbreak linked to Taco Bell affecting sales. Shares are trading higher in after-market hours, continuing recent upward momentum.

30 Jul 2026, 23:46 UTC

News

Shares of Netflix are lower in after-market trading following Anne Sweeney's resignation from the board, confirmed not to be due to any disagreement.

30 Jul 2026, 23:41 UTC

News

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

30 Jul 2026, 23:41 UTC

Social Media
Event
News

Karyopharm Therapeutics shares fell sharply after its Phase 3 trial for selinexor failed to meet key endpoints, leading to a shift in focus away from endometrial cancer.

30 Jul 2026, 23:41 UTC

Social Media
Correlated Moves
News

MicroStrategy reported a second-quarter loss of $8.62 billion, significantly missing expectations. Shares are trading higher in after-market hours amid broader market gains.

30 Jul 2026, 23:41 UTC

News
Social Media

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

30 Jul 2026, 23:41 UTC

Social Media
News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

30 Jul 2026, 23:41 UTC

News

Cerus Corporation shares declined in after-market hours following a revenue miss and lowered full-year guidance, despite second-quarter earnings matching estimates.

30 Jul 2026, 23:41 UTC

News

Cognizant Technology Solutions shares are lower in after-market trading despite stable revenue and increased profit guidance in its recent second-quarter update.

30 Jul 2026, 23:41 UTC

Correlated Moves
News
Social Media

Micron Technology's after-market hours trading rises significantly, driven by a broader market rally and a $153 billion increase in market capitalization.

30 Jul 2026, 23:41 UTC

News

Bloom Energy Corp shares are higher in after-market hours, driven by strong performance in the Heavy Electrical Equipment sector and significant revenue growth.

30 Jul 2026, 23:41 UTC

News

PTC Inc. gained in after-market hours, driven by strong quarterly results and raised revenue guidance, reaching a high of 2.82% since Thursday's close.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

35.21% upside

12 Months Forecast

Average 230 EUR  35.21%

High 260 EUR

Low 210 EUR

Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Sentiment

By Acuity

14 / 438 Finance

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat